Richard S Schofield

Richard S Schofield, MD, FACC

PROFESSOR

Department: MD-CARDIOLOGY
Business Phone: (352) 548-4014
Business Email: schofrs@medicine.ufl.edu

About Richard S Schofield

Dr. Richard S. Schofield is a Professor of Medicine in the Division of Cardiovascular Medicine at the University of Florida College of Medicine in Gainesville.  He is also the Vice Chairman for Veterans Affairs within the Department of Medicine at the University of Florida and he is Chief of the Medical Service for the North Florida/South Georgia Veterans Health System, one of the largest integrated health systems in the Veterans Health Administration.   Since 1997, Dr. Schofield has also served as an Attending Cardiologist in the adult Heart Failure/Heart Transplant Program at the University of Florida and the Shands Transplant Center.   

From 2001-2010, Dr. Schofield led the Cardiology Section at the Malcom Randall VA Medical Center in Gainesville, Florida.  In that capacity Dr. Schofield supervised one of the busiest cardiovascular programs in the VA.  Dr. Schofield has received local, regional, and national awards from the Department of Veterans Affairs for Quality Improvement and/or Systems Redesign.  In 2007, Dr. Schofield was named to the national VA Cardiology Field Advisory Committee, and in 2011 he was named as the VA representative to the American College of Cardiology Board of Governors.

Dr. Schofield is a Fellow of the American College of Cardiology and the American Heart Association.  He is the director of an award-winning  telehealth heart failure management program affiliated with the VA Office of Telehealth Services. 

Board Certifications

  • Advanced Heart Failure and Heart Transplantation
    American Board of Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Cardiology
Subspecialties
  • Cardiovascular Disease
Areas of Interest
  • Echocardiogram
  • Heart failure
  • Heart transplant

Publications

2022
Impact of Operator Volumes and Experience on Outcomes After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program.
Cardiovascular revascularization medicine : including molecular interventions. 40:64-68 [DOI] 10.1016/j.carrev.2021.11.008. [PMID] 34774419.
2022
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
Cardiovascular drugs and therapy. 36(1):93-102 [DOI] 10.1007/s10557-020-07125-3. [PMID] 33400053.
2021
Clinical and Anatomic Complexity of Patients Undergoing Coronary Intervention With and Without On-Site Surgical Capabilities: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program.
Circulation. Cardiovascular interventions. 14(1) [DOI] 10.1161/CIRCINTERVENTIONS.120.009697. [PMID] 33354988.
2021
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.
Progress in cardiovascular diseases. 68:2-6 [DOI] 10.1016/j.pcad.2021.08.001. [PMID] 34371083.
2021
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
JAMA cardiology. 6(7):782-790 [DOI] 10.1001/jamacardio.2021.0683. [PMID] 33881448.
2021
Trends in cardiovascular procedural volumes in the setting of COVID-19: Insights from the VA clinical assessment, reporting, and tracking program.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 98(2):E326-E328 [DOI] 10.1002/ccd.29204. [PMID] 32833343.
2020
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study.
Circulation. Heart failure. 13(3) [DOI] 10.1161/CIRCHEARTFAILURE.119.006513. [PMID] 32093506.
2020
Outcomes Among Patients Undergoing Elective Percutaneous Coronary Intervention at Veterans Affairs and Community Care Hospitals.
Journal of the American College of Cardiology. 76(9):1112-1116 [DOI] 10.1016/j.jacc.2020.05.086. [PMID] 32854846.
2019
Engaging Cardiology Providers in Quality Measurement.
Journal of the American Heart Association. 8(9) [DOI] 10.1161/JAHA.119.012519. [PMID] 31020894.
2019
Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease.
JACC. Cardiovascular imaging. 12(7 Pt 1):1292-1293 [DOI] 10.1016/j.jcmg.2019.02.020. [PMID] 31005521.
2018
Ensuring Optimal Adjustment for Determinations of Institutional Quality.
JAMA cardiology. 3(11):1129-1130 [DOI] 10.1001/jamacardio.2018.3256. [PMID] 30304321.
2018
Temporal Trends in Coronary Angiography and Percutaneous Coronary Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program.
JACC. Cardiovascular interventions. 11(9):879-888 [DOI] 10.1016/j.jcin.2018.02.035. [PMID] 29747919.
2014
Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipients.
Interactive cardiovascular and thoracic surgery. 18(4):457-65 [DOI] 10.1093/icvts/ivt546. [PMID] 24421208.
2014
Likelihood of myocardial infarction during stroke rehabilitation preceded by cardiovascular screening and an exercise tolerance test: the Locomotor Experience Applied Post-Stroke (LEAPS) trial.
International journal of stroke : official journal of the International Stroke Society. 9(8):1097-104 [DOI] 10.1111/ijs.12354. [PMID] 25156340.
2013
A Multidisciplinary Disease Management Program Offers Sustained Improvement in Heart Failure-Specific Quality of Life
. 19
2013
Correlation Between Disease-Specific Quality of Life Tools in Recently Hospitalized Heart Failure Patients
. 19
2013
Does exercise tolerance testing at 60 days poststroke predict rehabilitation performance?
Archives of physical medicine and rehabilitation. 94(7):1223-9 [DOI] 10.1016/j.apmr.2013.01.031. [PMID] 23548545.
2013
Quality of Life Is Equally Impaired in Reduced and Preserved Ejection Fraction Heart Failure After Hospitalization
. 19:S41-S42
2013
The use of left ventricular assist devices in the treatment of class IV heart failure patients: what the non-heart failure specialist needs to know.
Cardiology in review. 21(1):37-41 [DOI] 10.1097/CRD.0b013e3182614f69. [PMID] 22643346.
2012
A Multivariate Analysis of Clinical Parameters That Affect Gene Expression Profile Assessment of Immune Activation
Journal of Heart and Lung Transplantation. 31:S163-S164
2012
CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults.
Human genomics. 6(1) [DOI] 10.1186/1479-7364-6-9. [PMID] 23245743.
2011
Coenzyme q10 and creatine in heart failure: micronutrients, macrobenefit?
Clinical cardiology. 34(4):196-7 [DOI] 10.1002/clc.20892. [PMID] 21462213.
2011
Coronary artery involvement in cardiac amyloidosis.
Clinical research in cardiology : official journal of the German Cardiac Society. 100(11):1045-6 [DOI] 10.1007/s00392-011-0342-z. [PMID] 21744170.
2011
Exercise Tolerance Test Performance in Subacute Stroke Across Severity Levels
. 42
2011
Prevalence and Clinical Features of Heart Failure With Preserved Ejection Fraction in a Veterans Administration Medical Center
. 17
2009
A Novel Heart Failure Disease Management Strategy Reduces Heart Failure Readmissions in Veterans With Heart Failure
. 15
2009
Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Journal of the American College of Cardiology. 54(22):1993-2000 [DOI] 10.1016/j.jacc.2009.07.039. [PMID] 19926003.
2009
Constrictive pericarditis presenting as a calcified anterior cardiac mass.
The Annals of thoracic surgery. 87(5):1597-9 [DOI] 10.1016/j.athoracsur.2008.10.005. [PMID] 19379918.
2009
Heart Failure-Specific Quality of Life Is Variably Impaired in Veterans With Heart Failure
. 15
2009
Low Utilization of Aldosterone Antagonists (Aa) and Digoxin Upon Hospital Discharge in Veterans Consulted To a Two-Tiered Interventional, Multi-Disciplinary Heart Failure Disease Management Program (Hfdmp)
. 15
2009
Percutaneous Coronary Intervention for Treatment of Symptomatic Ischemic Heart Failure With Normal Left Ventricular Systolic Function
Journal of the American College of Cardiology. 53
2009
Quality of Life Differences in Heart Failure Drug Combinations
. 15
2009
Sociodemographic Barriers To Implementation of Heart Failure Disease Management Within a Veterans Administration Medical Center
. 15
2008
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
The American journal of gastroenterology. 103(11):2890-907 [DOI] 10.1111/j.1572-0241.2008.02216.x. [PMID] 18853965.
2008
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Journal of the American College of Cardiology. 52(18):1502-17 [DOI] 10.1016/j.jacc.2008.08.002. [PMID] 19017521.
2008
Effects of exercise training on forearm and calf vasodilation and proinflammatory markers in recent heart transplant recipients: a pilot study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 15(1):10-8 [DOI] 10.1097/HJR.0b013e3282f0b63b. [PMID] 18277180.
2008
Exercise training attenuates progressive decline in brachial artery reactivity in heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 27(1):52-9 [DOI] 10.1016/j.healun.2007.09.032. [PMID] 18187087.
2008
Incidence, predictors, and outcomes of cardiac pacing after cardiac transplantation: an 11-year retrospective analysis.
Transplantation. 85(8):1216-8 [DOI] 10.1097/TP.0b013e31816b677c. [PMID] 18431245.
2008
Plasma Coenzyme Q10 Predicts Lipid-lowering Response to High-Dose Atorvastatin.
Journal of clinical lipidology. 2(4):289-97 [DOI] 10.1016/j.jacl.2008.05.001. [PMID] 19649137.
2008
Response To Exercise Tolerance Testing in Subacute Stroke Across Severity Levels
. 39:618-619
2008
Telehealth Management of Heart Failure Improves Cardiac Remodeling
Journal of Cardiac Failure. 14(6):S114-S115 [DOI] 10.1016/j.cardfail.2008.06.398.
2008
Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 27(10):1102-7 [DOI] 10.1016/j.healun.2008.07.022. [PMID] 18926401.
2007
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography).
Circulation. 115(3):402-26 [PMID] 17220398.
2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
Journal of the American College of Cardiology. 49(12):1373-412 [PMID] 17394977.
2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
Circulation. 115(12):1656-95 [PMID] 17372165.
2007
Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device.
American journal of hypertension. 20(6):622-8 [PMID] 17531918.
2007
Association of diurnal blood pressure pattern with risk of hospitalization or death in men with heart failure.
Journal of cardiac failure. 13(8):656-62 [PMID] 17923358.
2007
Cardiac transplantation in patients with anti-phospholipid antibodies.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 26(3):299-301 [PMID] 17346636.
2007
Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices.
The Annals of thoracic surgery. 83(1):68-71; discussion 71 [PMID] 17184632.
2007
Initial heart rate and systolic blood pressure predict outcomes in chronic heart failure patients who are evaluated for cardiac transplant.
Clinical cardiology. 30(6):282-7 [PMID] 17551963.
2007
Role of heart failure etiology on arterial wave reflection in heart transplant recipients: relation with C-reactive protein.
Journal of hypertension. 25(11):2273-9 [PMID] 17921822.
2007
Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Pharmacogenetics and genomics. 17(4):277-82 [PMID] 17496726.
2006
Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study.
Pharmacotherapy. 26(11):1572-7 [PMID] 17064201.
2006
Atrial fibrillation as a cause of left ventricular dysfunction after cardiac transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 25(1):131-3 [PMID] 16399543.
2006
Complementary and alternative medicine use among individuals participating in research: implications for research and practice.
Pharmacotherapy. 26(12):1794-801 [PMID] 17125440.
2006
CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).
Cytokine. 33(5):258-63 [PMID] 16567110.
2006
Managing the post-left ventricular assist device patient.
Congestive heart failure (Greenwich, Conn.). 12(1):41-5 [PMID] 16470091.
2006
Mental stress provokes ischemia in coronary artery disease subjects without exercise- or adenosine-induced ischemia.
Journal of the American College of Cardiology. 47(5):987-91 [PMID] 16516082.
2006
Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors.
Pharmacotherapy. 26(3):333-40 [PMID] 16503719.
2006
Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.
Journal of cardiac failure. 12(3):171-6 [PMID] 16624680.
2005
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Clinical pharmacology and therapeutics. 77(3):127-37 [PMID] 15735607.
2005
Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
Pharmacogenetics and genomics. 15(4):227-34 [PMID] 15864115.
2005
Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids.
Pharmacotherapy. 25(5):756-61 [PMID] 15899737.
2005
Early outcomes of a care coordination-enhanced telehome care program for elderly veterans with chronic heart failure.
Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 11(1):20-7 [PMID] 15785217.
2005
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine).
Journal of the American College of Cardiology. 46(1):184-221 [PMID] 15992662.
2005
Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function.
Journal of the American College of Cardiology. 46(12):2193-8 [PMID] 16360045.
2005
Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration.
The American journal of cardiology. 95(7):889-91 [PMID] 15781026.
2004
Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 23(2):260-1 [PMID] 14761776.
2004
Effect of exercise training on central aortic pressure wave reflection in coronary artery disease.
American journal of hypertension. 17(6):540-3 [PMID] 15177529.
2004
Effect of exercise training on endothelial function in men with coronary artery disease.
The American journal of cardiology. 93(5):617-20 [PMID] 14996592.
2004
Left ventricular dysfunction after pericardiectomy for constrictive pericarditis.
The Annals of thoracic surgery. 77(4):1449-51 [PMID] 15063292.
2003
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
American heart journal. 145(2):324-9 [PMID] 12595851.
2003
Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations.
Clinical cardiology. 26(9):407-10 [PMID] 14524595.
2003
Images in cardiology: a case of giant left atrium.
Clinical cardiology. 26(4) [PMID] 12708626.
2003
Pharmacological treatment of patients with peripheral arterial disease.
Drugs. 63(7):637-47 [PMID] 12656644.
2003
Sustained use of nesiritide to aid in bridging to heart transplant.
Clinical cardiology. 26(5):211-4 [PMID] 12769247.
2003
The evolving role of nesiritide in advanced or decompensated heart failure.
Pharmacotherapy. 23(10):1266-80 [PMID] 14594345.
2003
Vascular effects of sildenafil in hypertensive cardiac transplant recipients.
American journal of hypertension. 16(10):874-7 [PMID] 14553969.
2002
Amplitude and timing of central aortic pressure wave reflections in heart transplant recipients.
American journal of hypertension. 15(9):809-15 [PMID] 12219877.
2002
Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report.
Transplantation. 73(6):907-10 [PMID] 11923690.
2002
Hormone therapy in men and risk of cardiac allograft rejection.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 21(4):493-5 [PMID] 11927227.
2002
Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center’s experience.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 21(8):860-6 [PMID] 12163085.
2002
The use of ranolazine in cardiovascular disease.
Expert opinion on investigational drugs. 11(1):117-23 [PMID] 11772326.
2002
Ventricular dyssynchrony in dilated cardiomyopathy: the role of biventricular pacing in the treatment of congestive heart failure.
Clinical cardiology. 25(8):357-62 [PMID] 12173901.
2001
Cardiac transplantation in a patient with hereditary hemochromatosis: role of adjunctive phlebotomy and erythropoietin.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 20(6):696-8 [PMID] 11404177.
2001
Psychological distress across the course of care: a case study from implantable cardioverter defibrillator to cardiac transplantation evaluation.
Clinical cardiology. 24(9):627-9 [PMID] 11558846.
2001
Role of metabolically active drugs in the management of ischemic heart disease.
American journal of cardiovascular drugs : drugs, devices, and other interventions. 1(1):23-35 [PMID] 14728049.
2000
Rate-responsive pacing improves exercise tolerance in heart transplant recipients: a pilot study.
Journal of cardiopulmonary rehabilitation. 20(6):377-82 [PMID] 11144044.
1997
Cardiac transplantation: the University of Florida experience.
Clinical transplants. 199-208 [PMID] 9919405.
1992
Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator.
Journal of the American College of Cardiology. 20(1):228-35 [PMID] 1607530.
1990
TxA2 inhibition and ischemia-induced loss of myocardial function and reactive hyperemia.
The American journal of physiology. 258(5 Pt 2):H1402-8 [PMID] 2159727.

Education

Fellowship – Cardiology
1997 · University of Florida
Residency – Internal Medicine
1994 · University of Florida
Internship – Internal Medicine
1992 · University of Florida
Medical Degree
1991 · University of Florida

Contact Details

Phones:
Business:
(352) 548-4014
Emails:
Addresses:
Business Mailing:
PO Box 100288
GAINESVILLE FL 32610
Business Street:
JHMHC JHMHC
GAINESVILLE FL 32611